Keywords
Last Name
Institution

Seth Epstein

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentOphthalmology
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wei Y, Gadaria-Rathod N, Epstein S, Asbell P. Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures. Invest Ophthalmol Vis Sci. 2013 Dec; 54(13):8327-36.
      View in: PubMed
    2. Epstein SP, Gadaria-Rathod N, Wei Y, Maguire MG, Asbell PA. HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease. Exp Eye Res. 2013 Jun; 111:95-104.
      View in: PubMed
    3. Wei Y, Pinhas A, Liu Y, Epstein S, Wang J, Asbell P. Isoforms of secretory group two phospholipase A (sPLA2) in mouse ocular surface epithelia and lacrimal glands. Invest Ophthalmol Vis Sci. 2012 May; 53(6):2845-55.
      View in: PubMed
    4. Wei Y, Epstein SP, Fukuoka S, Birmingham NP, Li XM, Asbell PA. sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model. Invest Ophthalmol Vis Sci. 2011 Jun; 52(7):4780-8.
      View in: PubMed
    5. Epstein SP, Chen D, Asbell PA. Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther. 2009 Oct; 25(5):415-24.
      View in: PubMed
    6. Epstein SP, Ahdoot M, Marcus E, Asbell PA. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther. 2009 Apr; 25(2):113-9.
      View in: PubMed
    7. Chen D, Wei Y, Li X, Epstein S, Wolosin JM, Asbell P. sPLA2-IIa is an inflammatory mediator when the ocular surface is compromised. Exp Eye Res. 2009 May; 88(5):880-8.
      View in: PubMed
    8. Sosa AB, Epstein SP, Asbell PA. Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells. Cornea. 2008 Sep; 27(8):930-4.
      View in: PubMed
    9. Goodkin ML, Epstein S, Asbell PA, Blaho JA. Nuclear translocation of NF-kappaB precedes apoptotic poly(ADP-ribose) polymerase cleavage during productive HSV-1 replication in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2007 Nov; 48(11):4980-8.
      View in: PubMed
    10. Epstein SP, Bottone EJ, Asbell PA. Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections. Eye Contact Lens. 2006 Sep; 32(5):240-4.
      View in: PubMed
    11. Epstein SP, Pashinsky YY, Gershon D, Winicov I, Srivilasa C, Kristic KJ, Asbell PA. Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model. BMC Ophthalmol. 2006; 6:22.
      View in: PubMed
    12. Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M, Epstein S. Age-related cataract. Lancet. 2005 Feb 12-18; 365(9459):599-609.
      View in: PubMed
    13. Epstein SP, Wolosin JM, Asbell PA. P63 expression levels in side population and low light scattering ocular surface epithelial cells. Trans Am Ophthalmol Soc. 2005; 103:187-99; discussion 199.
      View in: PubMed
    Epstein's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067